2015-2027 Global T-Cell Lymphoma Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 118 pages | ID: 24BBD5B190D8EN
Maia Research

Abstracts

The worldwide market for T-Cell Lymphoma is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Novartis
Biocryst Pharmaceuticals Inc.
Roche Holding
Spectrum Pharmaceuticals
Shionogi & Company Limited
Bristol-Myers Squibb
Johnson & Johnson
Genmab AS
Merck & Co. Inc.

Major Types Covered
Radiotherapy
Chemotherapy
Surgery and Stem Cell Transplantation

Major Applications Covered
Peripheral T-cell Lymphoma
Cutaneous T-cell Lymphoma
Anaplastic Large Cell Lymphoma
Angio-immuno-blastic T-cell Lymphoma
Other Types of Lymphoma

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global T-Cell Lymphoma Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the T-Cell Lymphoma Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE T-CELL LYMPHOMA MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL T-CELL LYMPHOMA MARKET-SEGMENTATION BY TYPE

5.1 Radiotherapy
5.2 Chemotherapy
5.3 Surgery and Stem Cell Transplantation

6 GLOBAL T-CELL LYMPHOMA MARKET-SEGMENTATION BY APPLICATION

6.1 Peripheral T-cell Lymphoma
6.2 Cutaneous T-cell Lymphoma
6.3 Anaplastic Large Cell Lymphoma
6.4 Angio-immuno-blastic T-cell Lymphoma
6.5 Other Types of Lymphoma

7 GLOBAL T-CELL LYMPHOMA MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Novartis
  8.1.1 Novartis Profile
  8.1.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.1.4 Novartis Business Overview/Recent Development/Acquisitions
8.2 Biocryst Pharmaceuticals Inc.
  8.2.1 Biocryst Pharmaceuticals Inc. Profile
  8.2.2 Biocryst Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Biocryst Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
  8.2.4 Biocryst Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.3 Roche Holding
  8.3.1 Roche Holding Profile
  8.3.2 Roche Holding Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Roche Holding Product/Solution Launches and Enhancements Analysis
  8.3.4 Roche Holding Business Overview/Recent Development/Acquisitions
8.4 Spectrum Pharmaceuticals
  8.4.1 Spectrum Pharmaceuticals Profile
  8.4.2 Spectrum Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Spectrum Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.4.4 Spectrum Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.5 Shionogi & Company Limited
  8.5.1 Shionogi & Company Limited Profile
  8.5.2 Shionogi & Company Limited Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Shionogi & Company Limited Product/Solution Launches and Enhancements Analysis
  8.5.4 Shionogi & Company Limited Business Overview/Recent Development/Acquisitions
8.6 Bristol-Myers Squibb
  8.6.1 Bristol-Myers Squibb Profile
  8.6.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.6.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.7 Johnson & Johnson
  8.7.1 Johnson & Johnson Profile
  8.7.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.7.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.8 Genmab AS
  8.8.1 Genmab AS Profile
  8.8.2 Genmab AS Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Genmab AS Product/Solution Launches and Enhancements Analysis
  8.8.4 Genmab AS Business Overview/Recent Development/Acquisitions
8.9 Merck & Co. Inc.
  8.9.1 Merck & Co. Inc. Profile
  8.9.2 Merck & Co. Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Merck & Co. Inc. Product/Solution Launches and Enhancements Analysis
  8.9.4 Merck & Co. Inc. Business Overview/Recent Development/Acquisitions

9 GLOBAL T-CELL LYMPHOMA MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America T-Cell Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America T-Cell Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America T-Cell Lymphoma Production Analysis from 2015-2020
10.4 North America T-Cell Lymphoma Consumption Analysis from 2015-2020
10.5 North America T-Cell Lymphoma Import and Export from 2015-2020
10.6 North America T-Cell Lymphoma Value, Production and Market Share by Type (2015-2020)
10.7 North America T-Cell Lymphoma Consumption, Value and Market Share by Application (2015-2020)
10.8 North America T-Cell Lymphoma by Country (United States, Canada)
  10.8.1 North America T-Cell Lymphoma Sales by Country (2015-2020)
  10.8.2 North America T-Cell Lymphoma Consumption Value by Country (2015-2020)
10.9 North America T-Cell Lymphoma Market PEST Analysis

11 EUROPE

11.1 Europe T-Cell Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe T-Cell Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe T-Cell Lymphoma Production Analysis from 2015-2020
11.4 Europe T-Cell Lymphoma Consumption Analysis from 2015-2020
11.5 Europe T-Cell Lymphoma Import and Export from 2015-2020
11.6 Europe T-Cell Lymphoma Value, Production and Market Share by Type (2015-2020)
11.7 Europe T-Cell Lymphoma Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe T-Cell Lymphoma by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe T-Cell Lymphoma Sales by Country (2015-2020)
  11.8.2 Europe T-Cell Lymphoma Consumption Value by Country (2015-2020)
11.9 Europe T-Cell Lymphoma Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific T-Cell Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific T-Cell Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific T-Cell Lymphoma Production Analysis from 2015-2020
12.4 Asia-Pacific T-Cell Lymphoma Consumption Analysis from 2015-2020
12.5 Asia-Pacific T-Cell Lymphoma Import and Export from 2015-2020
12.6 Asia-Pacific T-Cell Lymphoma Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific T-Cell Lymphoma Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific T-Cell Lymphoma by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific T-Cell Lymphoma Sales by Country (2015-2020)
  12.8.2 Asia-Pacific T-Cell Lymphoma Consumption Value by Country (2015-2020)
12.9 Asia-Pacific T-Cell Lymphoma Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America T-Cell Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America T-Cell Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America T-Cell Lymphoma Production Analysis from 2015-2020
13.4 Latin America T-Cell Lymphoma Consumption Analysis from 2015-2020
13.5 Latin America T-Cell Lymphoma Import and Export from 2015-2020
13.6 Latin America T-Cell Lymphoma Value, Production and Market Share by Type (2015-2020)
13.7 Latin America T-Cell Lymphoma Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America T-Cell Lymphoma by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America T-Cell Lymphoma Sales by Country (2015-2020)
  13.8.2 Latin America T-Cell Lymphoma Consumption Value by Country (2015-2020)
13.9 Latin America T-Cell Lymphoma Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa T-Cell Lymphoma Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa T-Cell Lymphoma Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa T-Cell Lymphoma Production Analysis from 2015-2020
14.4 Middle East & Africa T-Cell Lymphoma Consumption Analysis from 2015-2020
14.5 Middle East & Africa T-Cell Lymphoma Import and Export from 2015-2020
14.6 Middle East & Africa T-Cell Lymphoma Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa T-Cell Lymphoma Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa T-Cell Lymphoma by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa T-Cell Lymphoma Sales by Country (2015-2020)
  14.8.2 Middle East & Africa T-Cell Lymphoma Consumption Value by Country (2015-2020)
14.9 Middle East & Africa T-Cell Lymphoma Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL T-CELL LYMPHOMA MARKET FROM 2020-2027

15.1 Future Forecast of the Global T-Cell Lymphoma Market from 2020-2027 Segment by Region
15.2 Global T-Cell Lymphoma Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global T-Cell Lymphoma Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global T-Cell Lymphoma Market Value ($) and Growth Rate of T-Cell Lymphoma from 2015-2027
Global T-Cell Lymphoma Production and Growth Rate Segment by Product Type from 2015-2027
Global T-Cell Lymphoma Consumption and Growth Rate Segment by Application from 2015-2027
Figure T-Cell Lymphoma Picture
Table Product Specifications of T-Cell Lymphoma
Table Driving Factors for this Market
Table Industry News of T-Cell Lymphoma Market
Figure Value Chain Status of T-Cell Lymphoma
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global T-Cell Lymphoma Production and Growth Rate Segment by Product Type from 2015-2020
Table Global T-Cell Lymphoma Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Radiotherapy of T-Cell Lymphoma
Figure Chemotherapy of T-Cell Lymphoma
Figure Surgery and Stem Cell Transplantation of T-Cell Lymphoma
Table Global T-Cell Lymphoma Consumption and Growth Rate Segment by Application from 2015-2020
Table Global T-Cell Lymphoma Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Peripheral T-cell Lymphoma of T-Cell Lymphoma
Figure Cutaneous T-cell Lymphoma of T-Cell Lymphoma
Figure Anaplastic Large Cell Lymphoma of T-Cell Lymphoma
Figure Angio-immuno-blastic T-cell Lymphoma of T-Cell Lymphoma
Figure Other Types of Lymphoma of T-Cell Lymphoma
Table Global T-Cell Lymphoma Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global T-Cell Lymphoma Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of T-Cell Lymphoma
Figure Online Channel of T-Cell Lymphoma
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biocryst Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Biocryst Pharmaceuticals Inc. Sales and Growth Rate from 2015-2020
Figure Biocryst Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2015-2020
Table Biocryst Pharmaceuticals Inc. T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Holding Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Holding Sales and Growth Rate from 2015-2020
Figure Roche Holding Revenue ($) and Global Market Share from 2015-2020
Table Roche Holding T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Spectrum Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Spectrum Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Spectrum Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Spectrum Pharmaceuticals T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Shionogi & Company Limited Profile (Company Name, Plants Distribution, Sales Region)
Figure Shionogi & Company Limited Sales and Growth Rate from 2015-2020
Figure Shionogi & Company Limited Revenue ($) and Global Market Share from 2015-2020
Table Shionogi & Company Limited T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Genmab AS Profile (Company Name, Plants Distribution, Sales Region)
Figure Genmab AS Sales and Growth Rate from 2015-2020
Figure Genmab AS Revenue ($) and Global Market Share from 2015-2020
Table Genmab AS T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co. Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co. Inc. Sales and Growth Rate from 2015-2020
Figure Merck & Co. Inc. Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co. Inc. T-Cell Lymphoma Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global T-Cell Lymphoma Production Value ($) by Region from 2015-2020
Table Global T-Cell Lymphoma Production Value Share by Region from 2015-2020
Table Global T-Cell Lymphoma Production by Region from 2015-2020
Table Global T-Cell Lymphoma Consumption Value ($) by Region from 2015-2020
Table Global T-Cell Lymphoma Consumption by Region from 2015-2020
Table North America T-Cell Lymphoma Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America T-Cell Lymphoma Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America T-Cell Lymphoma Import and Export from 2015-2020
Table North America T-Cell Lymphoma Value ($) by Type (2015-2020)
Table North America T-Cell Lymphoma Production by Type (2015-2020)
Table North America T-Cell Lymphoma Consumption by Application (2015-2020)
Table North America T-Cell Lymphoma Consumption by Country (2015-2020)
Table North America T-Cell Lymphoma Consumption Value ($) by Country (2015-2020)
Figure North America T-Cell Lymphoma Market PEST Analysis
Table Europe T-Cell Lymphoma Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe T-Cell Lymphoma Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe T-Cell Lymphoma Import and Export from 2015-2020
Table Europe T-Cell Lymphoma Value ($) by Type (2015-2020)
Table Europe T-Cell Lymphoma Production by Type (2015-2020)
Table Europe T-Cell Lymphoma Consumption by Application (2015-2020)
Table Europe T-Cell Lymphoma Consumption by Country (2015-2020)
Table Europe T-Cell Lymphoma Consumption Value ($) by Country (2015-2020)
Figure Europe T-Cell Lymphoma Market PEST Analysis
Table Asia-Pacific T-Cell Lymphoma Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific T-Cell Lymphoma Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific T-Cell Lymphoma Import and Export from 2015-2020
Table Asia-Pacific T-Cell Lymphoma Value ($) by Type (2015-2020)
Table Asia-Pacific T-Cell Lymphoma Production by Type (2015-2020)
Table Asia-Pacific T-Cell Lymphoma Consumption by Application (2015-2020)
Table Asia-Pacific T-Cell Lymphoma Consumption by Country (2015-2020)
Table Asia-Pacific T-Cell Lymphoma Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific T-Cell Lymphoma Market PEST Analysis
Table Latin America T-Cell Lymphoma Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America T-Cell Lymphoma Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America T-Cell Lymphoma Import and Export from 2015-2020
Table Latin America T-Cell Lymphoma Value ($) by Type (2015-2020)
Table Latin America T-Cell Lymphoma Production by Type (2015-2020)
Table Latin America T-Cell Lymphoma Consumption by Application (2015-2020)
Table Latin America T-Cell Lymphoma Consumption by Country (2015-2020)
Table Latin America T-Cell Lymphoma Consumption Value ($) by Country (2015-2020)
Figure Latin America T-Cell Lymphoma Market PEST Analysis
Table Middle East & Africa T-Cell Lymphoma Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa T-Cell Lymphoma Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa T-Cell Lymphoma Import and Export from 2015-2020
Table Middle East & Africa T-Cell Lymphoma Value ($) by Type (2015-2020)
Table Middle East & Africa T-Cell Lymphoma Production by Type (2015-2020)
Table Middle East & Africa T-Cell Lymphoma Consumption by Application (2015-2020)
Table Middle East & Africa T-Cell Lymphoma Consumption by Country (2015-2020)
Table Middle East & Africa T-Cell Lymphoma Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa T-Cell Lymphoma Market PEST Analysis
Table Global T-Cell Lymphoma Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global T-Cell Lymphoma Production and Growth Rate Forecast by Region (2020-2027)
Table Global T-Cell Lymphoma Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global T-Cell Lymphoma Production and Growth Rate Forecast by Type (2020-2027)
Table Global T-Cell Lymphoma Consumption and Growth Rate Forecast by Application (2020-2027)